MEST and breast carcinoma: Moreover, analysis of MS-PCR appeared to show that the promoter region of the MEST was significantly hypomethylated in breast cancer tissues as opposed to normal adjacent tissues or, rather, MEST expression was regulated by ZFP57 through conserving its DNA methylation in breast cancer cells.